BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 10875787)

  • 1. Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses.
    Hoft DF; Brown RM; Belshe RB
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S217-22. PubMed ID: 10875787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M; Matsuo K; Honda M
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.
    Black GF; Weir RE; Floyd S; Bliss L; Warndorff DK; Crampin AC; Ngwira B; Sichali L; Nazareth B; Blackwell JM; Branson K; Chaguluka SD; Donovan L; Jarman E; King E; Fine PE; Dockrell HM
    Lancet; 2002 Apr; 359(9315):1393-401. PubMed ID: 11978337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytokine response to bacille Calmette Guérin vaccination in South India.
    Das SD; Narayanan PR; Kolappan C; Colston MJ
    Int J Tuberc Lung Dis; 1998 Oct; 2(10):836-43. PubMed ID: 9783532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin.
    Strapagiel D; Kasztalska K; Druszczyńska M; Kowalewicz-Kulbat M; Vrba A; Matusiak A; Chmiela M; Rudnicka W
    Folia Histochem Cytobiol; 2008; 46(3):353-9. PubMed ID: 19056540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi.
    Black GF; Fine PEM ; Warndorff DK; Floyd S; Weir RE; Blackwell JM; Bliss L; Sichali L; Mwaungulu L; Chaguluka S; Jarman E; Ngwira B; Dockrell HM
    Int J Tuberc Lung Dis; 2001 Jul; 5(7):664-72. PubMed ID: 11467373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guérin vaccination in northern Malawi.
    Floyd S; Pönnighaus JM; Bliss L; Nkhosa P; Sichali L; Msiska G; Fine PE
    J Infect Dis; 2002 Sep; 186(6):807-14. PubMed ID: 12198615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guérin.
    Kemp EB; Belshe RB; Hoft DF
    J Infect Dis; 1996 Jul; 174(1):113-9. PubMed ID: 8655980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination.
    Hoft DF; Leonardi C; Milligan T; Nahass GT; Kemp B; Cook S; Tennant J; Carey M
    Clin Infect Dis; 1999 Apr; 28(4):785-90. PubMed ID: 10825039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence and boosting of bacille Calmette-Guérin-induced delayed-type hypersensitivity.
    Hoft DF; Tennant JM
    Ann Intern Med; 1999 Jul; 131(1):32-6. PubMed ID: 10391813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
    Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
    Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine.
    Diness BR; Fisker AB; Roth A; Yazdanbakhsh M; Sartono E; Whittle H; Nante JE; Lisse IM; Ravn H; Rodrigues A; Aaby P; Benn CS
    Am J Clin Nutr; 2007 Oct; 86(4):1152-9. PubMed ID: 17921396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with Bacillus Calmette-Guérin at birth in Santiago, Chile.
    Sepulveda RL; Burr C; Ferrer X; Sorensen RU
    Pediatr Infect Dis J; 1988 Aug; 7(8):578-81. PubMed ID: 3140208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.
    Katial RK; Hershey J; Purohit-Seth T; Belisle JT; Brennan PJ; Spencer JS; Engler RJ
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):339-45. PubMed ID: 11238218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical inquiries. How should we manage a patient with a positive PPD and prior BCG vaccination?
    Rowland K; Guthmann R; Jamieson B; Malloy D
    J Fam Pract; 2006 Aug; 55(8):718-20. PubMed ID: 16882448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis.
    Elias D; Akuffo H; Britton S
    Trans R Soc Trop Med Hyg; 2005 May; 99(5):363-8. PubMed ID: 15780343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
    Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
    Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination.
    Hoft DF; Kemp EB; Marinaro M; Cruz O; Kiyono H; McGhee JR; Belisle JT; Milligan TW; Miller JP; Belshe RB
    J Lab Clin Med; 1999 Sep; 134(3):244-52. PubMed ID: 10482309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of cattle with Mycobacterium bovis BCG by a combination of systemic and oral routes.
    Buddle BM; Denis M; Aldwell FE; Martin Vordermeier H; Glyn Hewinson R; Neil Wedlock D
    Tuberculosis (Edinb); 2008 Nov; 88(6):595-600. PubMed ID: 18439875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.